IMMIX BIOPHARMA, INC.

Insiders Immix Biopharma, Inc.

Equities

IMMX

US45258H1068

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-04 pm EST			5-day change	1st Jan Change
4.840 ^USD	+16.63%		+12.56%	+120.00%

Nov. 12	Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer	CI
Nov. 07	Immix Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Insiders

Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer	Nov. 12	CI
Immix Biopharma, Inc. Appoints Nancy Chang, Ph.D. as A Member of the Board, Effective September 8, 2025	Sep. 08	CI
Immix Biopharma Announces Raymond Comenzo Joins Scientific Advisory Board of Nexcella Scientific Advisory	24-09-19	CI
Immix Biopharma, Inc. Appoints Yekaterina Chudnovsky as Member of the Board	23-08-22	CI
Insider Buy: Immix Biopharma	21-12-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

Optimize my profits